Reappraisal of the toxicology of ethylene glycol. 3. Mitochondrial effects.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002952:Citric Acid Cycle; D004285:Dogs; D005260:Female; D006016:Glycolates / Q000494:pharmacology; D006018:Glycols / Q000378:metabolism / Q000494:pharmacology*; D006038:Glyoxylates / Q000494:pharmacology; D000882:Haplorhini; D006885:Hydroxybutyrates / Q000494:pharmacology; D066298:In Vitro Techniques; D007521:Isocitrate Dehydrogenase / Q000378:metabolism; D007656:Ketoglutaric Acids / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000187:drug effects*; D008930:Mitochondria, Liver / Q000201:enzymology / Q000378:metabolism; D010070:Oxalates / Q000494:pharmacology; D010071:Oxaloacetates / Q000494:pharmacology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010088:Oxidoreductases / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D013386:Succinates / Q000494:pharmacology
D006016:Glycolates; D006018:Glycols; D006038:Glyoxylates; D006885:Hydroxybutyrates; D007656:Ketoglutaric Acids; D010070:Oxalates; D010071:Oxaloacetates; D013386:Succinates; D010088:Oxidoreductases; D007521:Isocitrate Dehydrogenase